March 8, 2018 / 5:31 AM / 7 months ago

BRIEF-Lupin Signs Agreement With CSIR-NCL And DST

March 8 (Reuters) - Lupin Ltd:

* SIGNS AGREEMENT WITH CSIR-NCL AND DST FOR DEVELOPMENT OF CONTINUOUS MANUFACTURING PROCESS FOR BIOSIMILAR MONOCLONAL ANTIBODY THERAPEUTIC‍​ Source text: bit.ly/2tuFC1Q Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below